AMZN
Amazon.com, Inc.
AMZN has the edge over CPRI overall, supported by stronger valuation and lower modeled downside.
CPRI
Capri Holdings Limited
CPRI's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CPRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
CPRI's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CPRI in the historical PE scenario, which offers more potential upside but is not a forecast.
CPRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $14.12 | -31% |
| Forward | 9.4x | $20.38 | — |
| Current | 12x | $20.38 | — |
| Fair | 13x | $23.01 | +13% |
| Expensive | 21x | $36.91 | +81% |
Historical ranges are pointers, not guarantees.
CPRI's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 9.4x next year's earnings, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CPRI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CPRI's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CPRI on earnings, with more consistent year-over-year improvement.
CPRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.17 | +23% |
| Q3 2026 | $1.77 | +$11.64 |
| Q2 2026 | $1.30 | +$10.75 |
| Q1 2026 | $1.14 | +$11.14 |
| Q4 2025 | -$4.30 | +$4.24 |
| Q3 2025 | -$9.87 | -$6.82 |
| Q2 2025 | -$9.45 | -$6.97 |
| Q1 2025 | -$10.00 | -$8.04 |
| Q4 2024 | -$8.54 | -547% |
CPRI has returned to profit: it earned $1.77 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CPRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CPRI on profitability, with a higher operating margin.
CPRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $809M | -5.5% |
| Q2 2026 | $769M | -3.5% |
| Q1 2026 | $796M | -23% |
| Q4 2025 | $1B | -19% |
| Q3 2025 | $856M | -21% |
| Q2 2025 | $797M | -25% |
| Q1 2025 | $1B | -15% |
| Q4 2024 | $1.3B | -12% |
CPRI's revenue has slid since its 2021 peak: $809M last quarter, down 5.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.2% | +2.6 points |
| Q2 2026 | 2.2% | +0.2 points |
| Q1 2026 | -3.4% | +7.8 points |
| Q4 2025 | 4.5% | +51 points |
| Q3 2025 | -1.4% | +2.1 points |
| Q2 2025 | 2% | +2.8 points |
| Q1 2025 | -11% | +33 points |
| Q4 2024 | -47% | -55 points |
CPRI's operating margin was 1.2% last quarter, up 2.6 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CPRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $36M | +$101M |
| Q2 2026 | $48M | +$69M |
| Q1 2026 | -$83M | +$105M |
| Q4 2025 | $183M | -34% |
| Q3 2025 | -$65M | -383% |
| Q2 2025 | -$21M | -153% |
| Q1 2025 | -$188M | -$182M |
| Q4 2024 | $278M | -11% |
CPRI has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CPRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.9% | -5.7M shares |
| 1 year | -7.9% | -9.4M shares |
| 3 years | -6.1% | -7.2M shares |
| 5 years | -28% | -43.9M shares |
| Available history | -27% | -41.8M shares |
CPRI has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150M |
| Q2 2026 | $54M |
| Q1 2026 | $79M |
| Q4 2025 | — |
| Q3 2025 | $1M |
| Q2 2025 | $1M |
| Q1 2025 | — |
| Q4 2024 | — |
CPRI spent $283M buying back its own shares over the past year, more than ten times what it spent the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over CPRI on leverage, with a lower net debt burden relative to earnings.
CPRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2023 | 3.9x | Elevated |
| Q3 2023 | 3.6x | Elevated |
| Q2 2023 | 2.5x | Moderate |
| Q1 2023 | 1.9x | Healthy |
CPRI's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.9 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CPRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 88.5 | Overbought |
CPRI's weekly RSI is 64 (neutral) and its Stochastic is 88 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
CPRI PE vs Consumer Cyclical Sector
| Metric | CPRI | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 36% below |
| PE % | 43 | 47 | 4 pts below |
CPRI has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CPRI on trend strength, trading above more of its moving averages.
CPRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.0 | 20% above |
| 20 week MA | $16.0 | 27% above |
| 50 week MA | $19.1 | 6.9% above |
| 100 week MA | $19.5 | 4.5% above |
| 200 week MA | $30.6 | 33% below |
CPRI has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 33% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CPRI on returns for 2026, with the stronger performance.
CPRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.5 | $42.4 | +13% |
| 2021 | $42.4 | $61.7 | +45% |
| 2022 | $61.7 | $55.7 | -9.7% |
| 2023 | $55.7 | $50.2 | -9.8% |
| 2024 | $50.2 | $21.0 | -58% |
| 2025 | $21.0 | $25.0 | +19% |
| 2026 YTD | $25.0 | $20.4 | -18% |
CPRI has finished lower in three of the last six years. It's down 18% so far in 2026.